Medbot Surgical Sustainability Profile
Medbot Surgical, a leading innovator in the medical technology sector, is headquartered in China (CN) and operates extensively across Asia and Europe. Founded in 2015, the company has rapidly established itself in the surgical robotics industry, focusing on advanced robotic-assisted surgical systems that enhance precision and efficiency in operating rooms. Medbot Surgical's flagship products, including the Medbot Surgical Robot, are designed to improve patient outcomes through minimally invasive procedures. The company is recognised for its commitment to research and development, which has led to significant advancements in surgical techniques and technologies. With a strong market position, Medbot Surgical has garnered accolades for its contributions to healthcare, positioning itself as a trusted partner for medical professionals worldwide.
DitchCarbon Score
How does Medbot Surgical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medbot Surgical's score of 24 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medbot Surgical's reported carbon emissions
Medbot Surgical, headquartered in China (CN), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Shanghai MicroPort MedBot (Group) Co., Ltd., which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Medbot Surgical. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. Given its affiliation with Shanghai MicroPort MedBot (Group) Co., Ltd., it is important to note that any climate commitments or emissions data may be inherited from this parent organization. However, no specific details regarding emissions or targets from the parent company have been provided. In the broader context of the industry, companies are increasingly focusing on sustainability and carbon reduction, often setting ambitious targets aligned with global climate initiatives. Medbot Surgical's future climate commitments will be crucial in aligning with these industry standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 4,810 |
| Scope 2 | 1,478,550 |
| Scope 3 | - |
How Carbon Intensive is Medbot Surgical's Industry?
How Carbon Intensive is Medbot Surgical's Location?
Medbot Surgical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medbot Surgical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
